Cite
MLA Citation
Zhuhang Huang et al.. “Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in Chinese females aged 9 to 26 years: A phase 3, open-label, immunobridging study.” Vaccine, vol. 39, no. 4, 2021, pp. 760–766. http://access.bl.uk/ark:/81055/vdc_100119754570.0x000046